Michael Robinson
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Seqirus USA Inc accounts for 75.9% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $7,133 and has fallen 83.7% since, to $1,163 in 2025. Among family clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $104.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seqirus USA Inc$12K
- Johnson & Johnson$957
- AbbVie$413
- Sanofi$289
- Lilly USA, LLC$277
- Regeneron Healthcare Solutions, Inc.$255
- plus $2K from 22 others
What the payments were for
- Consulting fees$7065%
- Speaking & faculty fees$8,56855%
- Travel & lodging$2,50716%
- Food & beverage$3,50123%
- Education$2752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seqirus USA Inc | 9 | $11,806 |
| Johnson & Johnson | 16 | $957 |
| AbbVie | 31 | $413 |
| Sanofi | 4 | $289 |
| Lilly USA, LLC | 14 | $277 |
| Regeneron Healthcare Solutions, Inc. | 11 | $255 |
| Dermavant Sciences, Inc. | 10 | $181 |
| LEO Pharma Inc. | 7 | $163 |
| Sun Pharmaceutical Industries Inc. | 4 | $160 |
| Amgen | 3 | $140 |
| Novartis | 2 | $112 |
| Organon | 8 | $112 |
| Incyte Corporation | 5 | $109 |
| AstraZeneca | 1 | $100 |
| Galderma Laboratories, L.p. | 4 | $78 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Genentech USA, Inc. | 1 | $44 |
| Pfizer | 2 | $44 |
| Biofrontera Inc. | 2 | $39 |
| UCB, Inc. | 2 | $39 |
| Journey Medical Corporation | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Merz North America, Inc. | 1 | $25 |
| Boston Scientific | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,557 in reported general payments places this provider in the 95th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 17 | $1,224 |
| Clobetasol Propionate | 18 | $751 |
| Minoxidil | 28 | $451 |
| Doxycycline Hyclate | 14 | $369 |
| Triamcinolone Acetonide | 31 | $296 |
| Ketoconazole | 20 | $240 |
| Mupirocin | 15 | $110 |
Paid to pharmacies, not to this prescriber.
Other family in Provo
- Kindra HuntProvo$118K
- Judd HunterProvo$32K
- Katelyn SianoProvo$29K
- Darin UsherProvo$15K
- Ashley RadmallProvo$8K
- Kylee MaliwaukiProvo$8K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.